World Health Organization site
Skip Navigation Links

Main
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 17 October 2012
Main ID:  NCT00529672
Date of registration: 13/09/2007
Primary sponsor: Erasmus Medical Center
Public title: Surgery or Noninvasive Therapy for Varicose Veins Magna
Scientific title: Randomized Single Center Comparative Study of the Treatment of Insufficient Greater Saphenous Vein: Surgery vs Ultrasound Guided Sclerotherapy With Foam and Endovenous Laser Therapy
Date of first enrolment: May 2007
Target sample size: 240
Recruitment status: Recruiting
URL:  http://clinicaltrials.gov/show/NCT00529672
Study type:  Interventional
Study design:  Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment  
Countries of recruitment
Netherlands
Contacts
Name:   Michael Kockaert, MD
Address: 
Telephone: 31 10 4634580
Email: m.kockaert@erasmusmc.nl
Affiliation: 
Name:   Michael Kockaert, MD
Address: 
Telephone: 31 10 4634580
Email: M.KOCKAERT@ERASMUSMC.NL
Affiliation: 
Name:   Martino Neumann, MD, PhD
Address: 
Telephone:
Email:
Affiliation:  Erasmus MC
Key inclusion & exclusion criteria

Inclusion Criteria:

- primary insufficient GSV confirmed by US: reflux>0.5 sec and diameter>0.5cm.

- non-treated insufficient GSV

- >18 years

- informed consent

Exclusion Criteria:

- acute thrombosis or phlebitis

- absence of deep venous system

- vascular syndromes

- use of anticoagulants

- contraindications surgery



Age minimum: 18 Years
Age maximum: 80 Years
Gender: Both
Health Condition(s) or Problem(s) studied
Varicose Vein
Intervention(s)
Procedure: crossectomy and short stripping
Procedure: endovenous laser therapy
Procedure: ultrasound guided sclerotherapy with foam
Primary Outcome(s)
anatomical success rate (absence or obliteration of GSV on US examination) [Time Frame: 3 months, 1 and 5 years]
Secondary Outcome(s)
cost effectiveness analysis [Time Frame: 3 months, 1 and 5 years]
patient reported outcomes (HRQOL and treatment satisfaction) [Time Frame: 3 months, 1 and 5 years]
treatment related adverse events and complications [Time Frame: 3 months, 1 and 5 years]
Secondary ID(s)
2005-325
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.1 - Version history